Demyelination and remyelination in anatomically distinct regions of the corpus callosum following cuprizone intoxication

Multiple sclerosis is a chronic demyelinating disease of the central nervous system. Spontaneous remyelination during early disease stages is thought to preserve and partially restore function. However, this process ceases in later stages despite the presence of pre-oligodendrocytes. Cuprizone-induced demyelination is a useful model with which to study the remyelination process. Previous studies have demonstrated heterogeneities in demyelination in individual animals. Here we investigated regional differences in demyelination and remyelination within the corpus callosum. C57BL/6 mice were fed 0.2% cuprizone for 5 weeks to induce demyelination. Remyelination was examined 2-5 weeks after cuprizone withdrawal. Immunohistochemistry and electron microscopy were used to quantify regional differences in demyelination, gliosis, and remyelination. We found that, while demyelination was limited in the rostral region of corpus callosum, nearly complete demyelination occurred in the caudal callosum, beginning at approximately -0.5mm from bregma. Astrogliosis and microgliosis were correlated with demyelination and differed between the rostral and caudal callosal structures. Remyelination upon cessation of cuprizone ensued at different rates with splenium remyelinating faster than dorsal hippocampal commissure. Our data show anatomical differences of cuprizone-induced demyelination and remyelination in the corpus callosum and the importance of examining specific callosal regions in myelin repair studies using this model.

[1]  K. Takakusaki,et al.  Differential changes in axonal conduction following CNS demyelination in two mouse models , 2008, The European journal of neuroscience.

[2]  P. Carmeliet,et al.  Gas6 Deficiency Increases Oligodendrocyte Loss and Microglial Activation in Response to Cuprizone-Induced Demyelination , 2008, The Journal of Neuroscience.

[3]  Ueli Suter,et al.  Quantifying the Early Stages of Remyelination Following Cuprizone‐induced Demyelination , 2003, Brain pathology.

[4]  W. L. Benedict,et al.  Multiple Sclerosis , 2007, Journal - Michigan State Medical Society.

[5]  L. Bö,et al.  Homogeneity of active demyelinating lesions in established multiple sclerosis , 2008, Annals of neurology.

[6]  Sjef Copray,et al.  The cuprizone animal model: new insights into an old story , 2009, Acta Neuropathologica.

[7]  George Paxinos,et al.  The Mouse Brain in Stereotaxic Coordinates , 2001 .

[8]  Qing Yang,et al.  MRI identification of the rostral‐caudal pattern of pathology within the corpus callosum in the cuprizone mouse model , 2008, Journal of magnetic resonance imaging : JMRI.

[9]  J. Ting,et al.  Cuprizone induces similar demyelination in male and female C57BL/6 mice and results in disruption of the estrous cycle , 2010, Journal of neuroscience research.

[10]  K Suzuki,et al.  TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. , 2001, Nature neuroscience.

[11]  P. Calabresi,et al.  MRI of the corpus callosum in multiple sclerosis: association with disability , 2010, Multiple sclerosis.

[12]  W. Blakemore.  Demyelination of the superior cerebellar peduncle in the mouse induced by cuprizone. , 1973, Journal of the neurological sciences.

[13]  J. Parisi,et al.  Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination , 2000, Annals of neurology.

[14]  Martin Stangel,et al.  Regional differences between grey and white matter in cuprizone induced demyelination , 2009, Brain Research.

[15]  D. Willenborg,et al.  Neuronal Nitric Oxide Synthase Plays a Key Role in CNS Demyelination , 2006, The Journal of Neuroscience.

[16]  Martin Stangel,et al.  Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent. , 2008, The American journal of pathology.

[17]  G. Kreutzberg,et al.  Isonicotinic acid hydrazide-induced spongy degeneration of the white matter in the brains of Pekin ducks. , 1966, The American journal of pathology.

[18]  Ludwin Sk.  Central nervous system demyelination and remyelination in the mouse: an ultrastructural study of cuprizone toxicity. , 1978 .

[19]  K. Irvine,et al.  Remyelination protects axons from demyelination-associated axon degeneration. , 2008, Brain : a journal of neurology.

[20]  J. Smirniotopoulos,et al.  Imaging evaluation of demyelinating processes of the central nervous system , 2010, Postgraduate Medical Journal.

[21]  W. Blakemore.  Observations on oligodendrocyte degeneration, the resolution of status spongiosus and remyelination in cuprizone intoxication in mice , 1972, Journal of neurocytology.

[22]  Ning Ma,et al.  Lower fractional anisotropy at the anterior body of the normal-appearing corpus callosum in multiple sclerosis versus symptomatic carotid occlusion , 2009, Neuroradiology.

[23]  H. Arnett,et al.  Astroglial‐derived lymphotoxin‐α exacerbates inflammation and demyelination, but not remyelination , 2005, Glia.

[24]  J. Taveras,et al.  Abnormal corpus callosum: a sensitive and specific indicator of multiple sclerosis. , 1991, Radiology.

[25]  R. Ransohoff,et al.  CXCR2-positive neutrophils are essential for cuprizone-induced demyelination: relevance to multiple sclerosis , 2010, Nature Neuroscience.

[26]  Charles Raybaud,et al.  The corpus callosum, the other great forebrain commissures, and the septum pellucidum: anatomy, development, and malformation , 2010, Neuroradiology.

[27]  M. Barnett,et al.  Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion , 2004, Annals of neurology.

[28]  R. Browning,et al.  Region-specific susceptibilities to cuprizone-induced lesions in the mouse forebrain: Implications for the pathophysiology of schizophrenia , 2009, Brain Research.

[29]  A. Trapp,et al.  Hexachlorophene Toxicosis in a Litter of Doberman Pinschers , 1990, Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc.

[30]  I. Duncan,et al.  Extensive remyelination of the CNS leads to functional recovery , 2009, Proceedings of the National Academy of Sciences.

[31]  S. Ludwin.  Central nervous system demyelination and remyelination in the mouse: an ultrastructural study of cuprizone toxicity. , 1978, Laboratory investigation; a journal of technical methods and pathology.

[32]  M. Stangel,et al.  Cerebellar Cortical Demyelination in the Murine Cuprizone Model , 2010, Brain pathology.

[33]  A. Chédotal,et al.  Promotion of central nervous system remyelination by induced differentiation of oligodendrocyte precursor cells , 2009, Annals of neurology.

[34]  G. Matsushima,et al.  SJL Mice Exposed to Cuprizone Intoxication Reveal Strain and Gender Pattern Differences in Demyelination , 2009, Brain pathology.

[35]  R. Klein,et al.  CXCR4 promotes differentiation of oligodendrocyte progenitors and remyelination , 2010, Proceedings of the National Academy of Sciences.

[36]  Glyn Johnson,et al.  Preferential occult injury of corpus callosum in multiple sclerosis measured by diffusion tensor imaging , 2004, Journal of magnetic resonance imaging : JMRI.

[37]  P. Morell,et al.  The Neurotoxicant, Cuprizone, as a Model to Study Demyelination and Remyelination in the Central Nervous System , 2001, Brain pathology.

[38]  L. Pasquini,et al.  The Neurotoxic Effect of Cuprizone on Oligodendrocytes Depends on the Presence of Pro-inflammatory Cytokines Secreted by Microglia , 2007, Neurochemical Research.

[39]  J. Ting,et al.  TNFα promotes proliferation of oligodendrocyte progenitors and remyelination , 2001, Nature Neuroscience.

[40]  K. Suzuki,et al.  Microglial/macrophage accumulation during cuprizone-induced demyelination in C57BL/6 mice , 1998, Journal of Neuroimmunology.

[41]  H. Hildebrandt,et al.  Demyelination of the hippocampus is prominent in the cuprizone model , 2009, Neuroscience Letters.

[42]  C. Beyer,et al.  Cuprizone effect on myelination, astrogliosis and microglia attraction in the mouse basal ganglia , 2009, Brain Research.

[43]  Anna C. Williams,et al.  Astrocytes—Friends or foes in multiple sclerosis? , 2007, Glia.

[44]  Sheng-Kwei Song,et al.  Reduced Axonopathy and Enhanced Remyelination After Chronic Demyelination in Fibroblast Growth Factor 2 (Fgf2)-Null Mice: Differential Detection With Diffusion Tensor Imaging , 2011, Journal of neuropathology and experimental neurology.

[45]  K. Suzuki,et al.  Status spongiosus of CNS and hepatic changes induced by cuprizone (biscyclohexanone oxalyldihydrazone). , 1969, The American journal of pathology.

[46]  Mingqiang Xie,et al.  Rostrocaudal Analysis of Corpus Callosum Demyelination and Axon Damage Across Disease Stages Refines Diffusion Tensor Imaging Correlations With Pathological Features , 2010, Journal of neuropathology and experimental neurology.

[47]  C. Beyer,et al.  Cuprizone Treatment Induces Distinct Demyelination, Astrocytosis, and Microglia Cell Invasion or Proliferation in the Mouse Cerebellum , 2009, The Cerebellum.